Jing Dong, PhD
Assistant Professor
Locations
- HRC 5860
Hematology and Oncology - Medicine
Cancer Prevention and Outcomes, Cancer Center
Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine
Biography
Dr. Dong is an assistant professor of medicine at the Medical College of Wisconsin, Division of Hematology and Oncology and also has a joint appointment with the Mellowes Center. Her research interests focus on integrating high-throughput “omics” data into epidemiological studies to develop approaches to reduce cancer burden and cancer disparities.
Dr. Dong received her PhD at Nanjing Medical University, China in 2012, then completed her training in epidemiology at National Institute of Environmental Health Sciences. Afterward, she was awarded by Cancer Prevention and Research Institute of Texas to join a training program in integrative cancer epidemiology at Baylor College of Medicine. Her work has led to more than 60 publications in several major high-ranking journals in cancer and genetic epidemiology areas, such as Nat Genet., Nat Commun., and Gastroenterology. She also serves as a reviewer for more than 20 international peer-reviewed journals, including but not limited to Communications Biology, Clin Gastroenterol Hepatol., Carcinogenesis, and as editorial board of BMC Cancer, Annals of Translational Medicine and Journal of Cancer Research Forecast.
Research Interests
Publications
-
(Buradagunta CS, Arsang-Jang S, Massat B, Thapa B, Patek V, D'Souza A, Auer P, Urrutia R, Janz S, Dhakal B, Hari P, Dong J.) Leukemia. 2023 Nov 02 PMID: 37919604 SCOPUS ID: 2-s2.0-85175540732 11/03/2023
-
(Mohan M, Janz S, Brazauskas R, Dwinell MB, Teng BQ, Yun G, Dong J, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, D'Souza A.) Bone Marrow Transplant. 2023 Aug;58(8):953-955 PMID: 37149674 PMCID: PMC10555486 SCOPUS ID: 2-s2.0-85158126520 05/07/2023
-
(Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, Deeg HJ, Nazha A, Carlson KS, Spellman S, Bolon YT, Saber W.) J Hematol Oncol. 2023 Apr 11;16(1):37 PMID: 37041565 PMCID: PMC10088148 SCOPUS ID: 2-s2.0-85152260295 04/12/2023
-
(Schröder J, Chegwidden L, Maj C, Gehlen J, Speller J, Böhmer AC, Borisov O, Hess T, Kreuser N, Venerito M, Alakus H, May A, Gerges C, Schmidt T, Thieme R, Heider D, Hillmer AM, Reingruber J, Lyros O, Dietrich A, Hoffmeister A, Mehdorn M, Lordick F, Stocker G, Hohaus M, Reim D, Kandler J, Müller M, Ebigbo A, Fuchs C, Bruns CJ, Hölscher AH, Lang H, Grimminger PP, Dakkak D, Vashist Y, May S, Görg S, Franke A, Ellinghaus D, Galavotti S, Veits L, Weismüller J, Dommermuth J, Benner U, Rösch T, Messmann H, Schumacher B, Neuhaus H, Schmidt C, Wissinowski TT, Nöthen MM, Wellcome Trust Case Control Consortium 2 (WTCCC2), Esophageal Adenocarcinoma Genetics Consortium (EAGLE), Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), Dong J, Ong JS, Buas MF, Thrift AP, Vaughan TL, Tomlinson I, Whiteman DC, Fitzgerald RC, Jankowski J, Vieth M, Mayr A, Gharahkhani P, MacGregor S, Gockel I, Palles C, Schumacher J.) Gut. 2023 Apr;72(4):612-623 PMID: 35882562 SCOPUS ID: 2-s2.0-85135474475 07/27/2022
-
Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis.
(Kim HS, Shetty PB, Tsavachidis S, Dong J, Amos CI, El-Serag HB, Thrift AP.) Clin Gastroenterol Hepatol. 2023 Apr;21(4):1023-1030.e39 PMID: 35680035 PMCID: PMC9722981 SCOPUS ID: 2-s2.0-85135349654 06/10/2022
-
(Dong J, Buradagunta CS, Zhang T, Spellman S, Bolon YT, DeZern AE, Gadalla SM, Deeg HJ, Nazha A, Cutler C, Cheng C, Urrutia R, Auer P, Saber W.) J Hematol Oncol. 2023 Mar 10;16(1):21 PMID: 36899395 PMCID: PMC9999628 SCOPUS ID: 2-s2.0-85149930611 03/11/2023
-
DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma.
(D'Souza A, Brazauskas R, Teng BQ, Yun G, Uttley H, Dong J, Dwinell MB, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, Janz S.) Bone Marrow Transplant. 2023 Mar;58(3):334-336 PMID: 36460820 SCOPUS ID: 2-s2.0-85143207078 12/03/2022
-
FOXM1 regulates glycolysis and energy production in multiple myeloma.
(Cheng Y, Sun F, Thornton K, Jing X, Dong J, Yun G, Pisano M, Zhan F, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Hari P, Janz S.) Oncogene. 2022 Aug;41(32):3899-3911 PMID: 35794249 PMCID: PMC9355869 SCOPUS ID: 2-s2.0-85133568311 07/07/2022
-
(Buradagunta CS, Garacci Z, D'Souza A, Dhakal B, Devata S, Janz S, Thrift AP, Hari P, Stolley M, Dong J.) Blood Cancer J. 2022 May 25;12(5):82 PMID: 35614050 PMCID: PMC9132975 SCOPUS ID: 2-s2.0-85130720530 05/26/2022
-
(Dong J, Garacci Z, Buradagunta CS, D'Souza A, Mohan M, Cunningham A, Janz S, Dhakal B, Thrift AP, Hari P.) Blood Cancer J. 2022 Feb 24;12(2):34 PMID: 35210395 PMCID: PMC8873507 SCOPUS ID: 2-s2.0-85125303734 02/26/2022
-
Impaired Plasma B Cell Markers in CD138+ Cells Predict Prognosis in Multiple Myeloma
(Dong J, Li J, Buradagunta CS, Janz S, Urrutia R, Cheng C.) Blood 2022; 140 (Supplement 1): 10054–10055.. 11/15/2022
-
(Massat B, Pareek G, Buradagunta CS, Thapa B, Auer P, Dhakal B, Janz S, Hari P, Dong J.) Blood 2022; 140 (Supplement 1): 10063–10064.. 11/15/2022